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Abstract 
Background and aims: Optical diagnosis allows for real-time endoscopic assessment of 
colorectal polyp histology and consists of the “resect and discard” and “diagnose and leave” 
paradigms. This survey assessed patient acceptance of optical diagnosis and their responses to a 
hypothetical doomsday scenario.   
Methods: A 3-month cross-sectional survey of colonoscopy outpatients presenting to an 
Australian academic endoscopy center.  
Results:  981 patients completed the survey (76.0% response rate). The 60.8% of patients who 
supported “resect and discard” were more likely to be older males who co-supported “diagnose 
and leave.” Fewer patients (49.6%) supported “diagnose and leave.” A family history of missed 
cancer diagnosis (OR 0.59, p= .003) was significantly associated with rejection of “resect and 
discard,” and a personal or family history of bowel cancer (OR 0.7, p= 0.04) was significantly 
associated with rejection of “diagnose and leave.” In the hypothetical scenario of a cancerous 
polyp incorrectly left in situ leading to Stage III disease; 208 patients (21.2%) would definitely 
ask for financial compensation, 584 (59.5%) were unsure, and 189 (19.3%) would definitely not 
seek compensation. The patient-proposed median value of compensation sought was 
A$1,000,000. Notably, 18.5% would be willing to give optical diagnosis another chance after 
this error.  
Conclusion: Patient support for optical diagnosis is limited and those who are not supporters are 
more likely to seek financial compensation if errors occur.  
 
Two colonoscopic management paradigms for diminutive polyps have been proposed: “resect 
and discard,” the paradigm in which adenomas are resected and then discarded without 
pathological confirmation; and “diagnose and leave,” the paradigm in which rectosigmoid 
hyperplastic polyps are left without resection.[1, 2]  Optical diagnosis is the fundamental 
cornerstone of both paradigms and represents the process of real-time assessment of all detected 
polyps during colonoscopy.[3-5] Using optical diagnosis allows surveillance recommendations 
to be made at the time of the procedure (and therefore included on the procedure report) and may 
also reduce the incidence of polypectomy related adverse events. Arguably, the most convincing 
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benefit of optical diagnosis is the substantial estimated reduction in global healthcare costs, 
mainly due to savings in pathology costs.[6-8] As diminutive colorectal polyps make up the 
majority of detected polyps at colonoscopy, the adoption of optical diagnosis is estimated confer 
a savings of USD$33 million per year in the United States alone.[6] 
 
However, widespread implementation of optical diagnosis in clinical practice hinges on 
widespread patient acceptance. Two recent surveys in the United States have reported conflicting 
patient preferences toward “resect and discard.” Although one survey reported that 66.3% would 
accept this paradigm,[9] another reported that at least 67.2% would pay $US150 of their own 
money per polyp for the histological assessment of a diminutive lesion.[10] Implicit in the 
rejection of “resect and discard” was the fear of unrecognized cancer being discarded and 
curative surgery not offered, leading to poor outcomes that may have been preventable.  
 
Terminal digit preference during endoscopic measurement[11], the curved fish-eye lens of 
modern colonoscopes[12] and the absence of binocular depth cues in display images[13] may 
limit the detection of pre-malignant and malignant lesions during optical diagnosis. “Diagnose 
and leave” is potentially more dangerous than “resect and discard,” as in the former strategy, 
these lesions are at risk of being left behind in error. The risk of interval cancer may also be 
compounded by inappropriately long surveillance intervals related to unrecognized rectosigmoid 
adenomas. This is represented by the doomsday scenario [14] of optical diagnosis in which 
patient harm is caused by human error. To our knowledge, no study has addressed patient 
preferences toward the “diagnose and leave” paradigm. 
 
The aim of this study was to explore the patient acceptance of both paradigms of optical 
diagnosis, and their responses to a hypothetical scenario in which a colorectal cancer was left 
behind in error. We hypothesized that personal or family history of colorectal cancer, and 
delayed diagnosis of any cancer, were associated with rejection of both paradigms. The 
secondary aim of this study was to determine factors that influenced their responses.  
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Methods 
Participants and setting 
We conducted a cross-sectional survey of patients presenting for colonoscopy to an Australian 
academic endoscopy center. Over a 3-month period, all consecutive outpatients scheduled to 
undergo colonoscopy for any indication were invited to participate. Patients were first asked if 
they were willing to consider participating in a research survey, and only patients who agreed 
were given the study title and the survey. Surveys were completed anonymously and did not 
contain any identifying information. This study was approved by the Metro South Health Service 
Human Research Ethics Committee, Brisbane. 
 
Survey design  
The survey was developed from existing instruments used in previous optical diagnosis 
research.[9, 10] Face-to-face meetings of all authors refined the questions through consensus. A 
reading level of sixth grade was targeted, and cultural appropriateness and English language 
proficiency used in survey construction.  The survey was approved by the ethics committee 
without further changes. 
 
Procedure 
A written survey was self-administered in the assessment area of the endoscopy unit between 
March 2016 and May 2016 (Appendix 1). Demographic information was collected on age, 
gender, income, highest level of education, number of previous colonoscopies and previous 
polypectomy. Patients were also asked if they had a personal or direct family history of 
colorectal cancer, and if they had a personal or direct family history of any missed cancer 
resulting in delay of treatment. Patients were then asked to read background information on both 
“resect and discard” and “diagnose and leave” paradigms (Appendix 1). Regarding “resect and 
discard,” patients were asked to indicate whether they would be willing or unwilling to have 
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diminutive polyps discarded, and the maximum out of pocket cost per diminutive polyp that they 
would be willing to pay for pathological assessment. Regarding “diagnose and leave,” patients 
were asked to indicate whether they would be willing or unwilling to have diminutive 
rectosigmoid hyperplastic polyps not resected during colonoscopy. Patients were then given a 
hypothetical scenario in which their endoscopist made a mistake and left behind a cancerous 
polyp which resulted in the patient developing metastatic disease requiring surgery (Stage III). In 
this scenario, patients were informed that their chance of survival after 5 years was 50%. Patients 
were first asked if they would seek financial compensation and if so, the amount of 
compensation that they would seek. Patients were also asked if they would give their endoscopist 
another chance to practice “diagnose and leave” on them in future colonoscopies.  
 
Statistics 
Only completed surveys were analyzed. Predictors of support for optical diagnosis were assessed 
using multiple logistic regression analyses. Statistical significance was set at .05. Analyses were 
performed on STATA 13.1 (StataCorp, College Station, Tex, USA).  
 
Results 
Patients 
All 1291 patients who had elective colonoscopies during the 3-month study period were 
approached, and 986 patients agreed to participate.  981 patients completed their surveys (76.0% 
response rate, 5 incomplete surveys). Of these, 425 (43.3%) were male and 556 (56.7%) were 
female. In terms of highest level of education, most patients (335, 34.2%) finished high school. 
Two hundred patients (25.7%) did not finish high school, 185 patients (18.9%) completed a 
technical certificate after high school, 106 patients (10.8%) completed a bachelor degree at 
university, and 103 (10.5%) patients completed higher degrees in university. Median and mean 
patient weekly incomes were A$425 and A$520, respectively. 
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Patient colonoscopy history 
Most patients (386, 39.4%) had never undergone colonoscopy, 275 patients (28.0%) had 1, 152 
patients (15.5%) had 2, 69 patients (7.0%) had 3, 37 patients (3.8%) had 4, and 62 patients 
(6.3%) had 5 or more colonoscopies. Of the 595 patients who had one or more previous 
colonoscopies, 397 patients (66.7%) reported to have had polyps removed.  
 
Experiences with colorectal cancer 
The majority of patients (680, 69.3%) had no personal or direct family history of colorectal 
cancer. We found that 41 patients (4.2%) reported a personal history, and 236 patients (24.1%) 
reported a direct family or friend history of missed cancer resulting in a delayed diagnosis.   
 
Support for optical diagnosis 
We found that 596 patients (60.8%) would support ‘resect and discard’ and 487 participants 
(49.6%) would support “diagnose and leave.” Four hundred and nine participants (41.7%) 
supported both paradigms and 307 (31.3%) would support neither. The median maximum out of 
pocket costs that patients were willing to pay for pathological assessment if it was not provided 
without co-payment, was A$25 ($19USD; $1 AUD = $0.76 USD).  
 
Regarding the hypothetical doomsday scenario in which an endoscopist left behind a cancerous 
polyp resulting in the patient developing Stage III metastatic disease (5-year survival rate of 
50%), 21.2% (208) of patients would “definitely” ask for monetary compensation, 59.5% (584) 
were “unsure” and 19.3% (189) would “definitely not” seek compensation. Of the 208 who 
would seek compensation, the median value of compensation requested was A$1,000,000 (range: 
A$100- A$10, 000,000); and 134 rejected diagnose and leave. Of the 189 who would definitely 
not seek compensation, 124 supported diagnose and leave. Notably, 181 patients (18.5%) would 
be willing to give optical diagnosis another chance after such an error; however, 416 patients 
(42.4%) would not, and 384 patients (39.1%) were unsure. 
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Factors associated with support of “resect and discard” on multivariate logistic regression 
analysis were older age (OR, 1.02; P = .003, 95% CI, 1.01 - 1.03), male gender (OR, 1.5; P = 
.01; 95% CI, 1.09 - 2.04), and co-support of “diagnose and leave” (OR, 8.3; P < .001; 95% CI, 
6.11 - 11.34). A family or friend history of missed cancer diagnosis (OR, 0.59; P = .003; 95% 
CI, 0.41 - 0.84) was significantly associated with rejection of “resect and discard.” In terms of 
“diagnose and leave,” co-support of “resect and discard” was the only significant association 
(OR, 8.4; P < .001; 95% CI, 6.14 - 11.42). A personal or family history of bowel cancer (OR, 
0.7; P = 0.04; 95% CI, 0.51 - 0.99) was significantly associated with rejection of “diagnose and 
leave.”  
 
On multivariate logistic regression analysis, patients who did not support “diagnose and leave” 
(OR, 1.9; P = .02; 95% CI, 1.12 - 3.13) and those who did not support “resect and discard” (OR, 
3.1; P = .001; 95% CI, 1.80 - 5.39) were more likely to seek compensation after the hypothetical 
doomsday scenario. Patients who would seek compensation were less likely to give “diagnose 
and leave” a second chance (OR, 0.57; P < .001; 95% CI, 0.46 - 0.73).  
 
Discussion 
The use of optical diagnosis is attractive from the perspective of health care economics. 
However, this Australian study of colonoscopy outpatients demonstrates that patient support of 
optical diagnosis is not assured. Support for management of diminutive polyps by “resect and 
discard” was 60.8% and for “diagnose and leave” was 49.6%. Only 41.7% of patient participants 
supported both paradigms of optical diagnosis. Although older males where more likely to be 
supporters, the best predictor of support for either paradigm was support for the other paradigm. 
This likely points to patients having an underlying acceptance of optical diagnosis as a whole. 
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A major impediment to realization of the potential global healthcare savings from use of optical 
diagnosis is poor patient acceptance. Our results support further research in financial modeling 
that combines both paradigms, adjusted for different rates of patient participation (Table 1). The 
American Gastroenterological Association has proposed a bundled payment framework for 
colorectal cancer screening and surveillance, which includes the costs of pathology.[15] Both 
paradigms of optical diagnosis may be attractive options for providing value-based care within 
this framework.[16-18] This study demonstrated that older males were more likely to support 
“resect and discard,” but no patient factors were associated with acceptance of “diagnose and 
leave.” This study confirms our hypothesis that there is a patient population less willing to accept 
optical diagnosis. We showed that a family or friend history of missed cancer diagnosis was 
significantly associated with rejection of “resect and discard,” and a personal or family history of 
bowel cancer was significantly associated with rejection of “diagnose and leave.”  
 
We explored the responses of patients to a so-called doomsday scenario[14]. Our patients were 
given a hypothetical scenario in which their endoscopist made a mistake and left behind a 
cancerous polyp, which resulted in the development of Stage III metastatic disease and a 5-year 
survival of 50%. When faced with such a scenario, up to 80.7% of patients would potentially 
seek financial compensation for a delayed diagnosis of cancer, and of those who indicated that 
they would seek compensation, the median value was A$1,000,000. This finding represents a 
warning against widespread implementation of optical diagnosis without engaging patient 
support.  
 
We found that patients who did not support “diagnose and leave” or “resect and discard” were 
more likely to seek compensation after our hypothetical doomsday scenario. These patients were 
also less likely to agree to have optical diagnosis performed on them again. Conversely, patients 
who supported optical diagnosis were less likely to seek financial compensation and were more 
likely to forgive. The medical legal ramifications of optical misdiagnosis need to be included in 
financial modeling of optical diagnosis. 
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There are limitations to this study. We included all outpatients scheduled for colonoscopy 
including those referred for diagnostic indications; it is possible that patients with symptoms may 
be less likely to accept optical diagnosis. The survey was conducted at a single academic 
endoscopic center and as such, it is not known if the results are generalizable to the wider 
community. Furthermore, to minimize questionnaire length and complexity, we did not provide 
comparative clinical or financial scenarios which may have influenced patient responses. An 
additional limitation was we elected not to verify the accuracy of patients’ responses to the 
demographic questions (income, education etc), or their reported experiences with cancer. In the 
latter example, 24.1% reported a direct family or friend history of missed cancer, which was a 
surprisingly high finding. As this survey targeted the perceptions of our patients, we felt that it 
was important to compare their beliefs with their potential acceptance of optical diagnosis. This 
study did not feature open-ended questions to capture the prevailing reasons behind their 
reservations. As some of these factors may be potentially modified or correctable, we welcome 
debate and encourage further research in this topic (Table 1).     
 
In conclusion, patient support for optical diagnosis is limited and those who are not supporters 
are more likely to seek financial compensation if errors occur. We recommend further study into 
measures to improve patient acceptance and ensure a patient centered approach before 
widespread implementation of optical diagnosis paradigms. 
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Appendix A 
 
This survey is about your opinion on the management of polyps at colonoscopy 
 
1) Age: _____   
 
2) Male  ☐   Female  ☐ 
 
3) How many colonoscopies have you had before today? (please tick ONE box only) 
1 ☐  2 ☐  3 ☐  4 ☐  5 or more ☐  
4) Did you have polyps on any previous colonoscopy? (please tick) 
Yes ☐  No ☐ 
5) Have you or a family member had bowel cancer?  (please tick) 
Yes ☐  No ☐ 
6) Have you had cancers that were picked up late or missed? (please tick) 
Yes ☐  No ☐  If yes, please provide details:  _____________________ 
__________________________________________________________________ 
7) Have any family or friends had cancers that were picked up late or missed?  
Yes ☐  No ☐  If yes, please provide details:  _____________________ 
__________________________________________________________________ 
8) What is your approximate gross weekly income?  
$__________ per week 
 
9) What is the highest level of education you have finished? (Please tick ONE box) 
☐
 Did not finish high school 
☐
 Finished high school 
☐
 Certificates I-IV 
☐
 Bachelor degree and honours 
☐
 Graduate Certificate and Graduate Diploma 
☐
 Masters 
☐
 Doctoral degree  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 10 
 
 
PLEASE READ THIS INFORMATION ABOUT COLON POLYPS 
 
Polyps are growths in the lining of the bowel.  Some polyps can turn into cancer and some can’t. 
Polyps that can grow into cancer are called precancerous.  
 
If we find a polyp during colonoscopy, the chance of cancer in that polyp is related to the size of 
the polyp: 
SIZE CHANCE OF CANCER 
10mm or larger 1 in 100 
6-9mm 1 in 500 
5mm or less Less than 1 in 1000 
 
The current policy for tiny polyps (5mm or smaller) is to remove ALL OF THEM and ask the 
pathologist to examine ALL OF THEM under the microscope for signs of cancer.  
 
Using modern colonoscopy cameras, doctors can tell which polyps are precancerous just by 
looking at them (their accuracy is the same as having the pathologist look at the polyp under the 
microscope). 
In a proposed NEW policy for tiny polyps (less than 5mm): 
 
a) Tiny polyps that your doctor examines and thinks are precancerous will be removed 
and discarded without being sent to the pathologist.  
Polyps larger than 5mm would still be sent to the pathologist for analysis. 
Your doctor will take high quality photographs of the polyps for the report. 
 
b) Tiny polyps that your doctor examines and thinks are not precancerous (5mm and 
smaller) will not be removed.  
Your doctor will take high quality photographs of the polyps for the report. 
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ONLY expert colonoscopy doctors with proper training using high-quality colonoscopes and 
permission from the hospital and medical association will be allowed to do this. 
If expert colonoscopy doctors remove tiny polyps that are considered precancerous and DO NOT 
send them to the pathologist for checking, researchers estimate large cost savings to our health 
system. 
10) What do you think about the policy of removing and discarding tiny polyps?  
 (Please tick ONE box only) 
☐
 THIS IS A GOOD IDEA: I agree to have my tiny polyps (with less than 1 in 
1000 chance of cancer) thrown away without being 
sent to the pathologist. It is a good way to reduce 
health care costs. 
☐
 THIS IS A BAD IDEA:  I want my tiny polyps checked by a pathologist. 
 
11) Suppose you have to pay for the pathology charges yourself (not Medicare or your 
insurance company).  Is there a price you would be willing to pay per tiny polyp 
removed to have them checked by the pathologist?   
Please circle the highest amount you would be willing to pay per polyp: 
$25 
$50 
$100 
$200 
$400 
$500 
$1000 
$2000 
$3000 
$4000 
$5000 
More than $5000 
Other amount you’d be willing to pay: $______ 
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If expert colonoscopy doctors remove ALL POLYPS they see, your risk from polyp removal of 
severe bleeding needing a hospital stay and emergency colonoscopy is about 0.5% (1 in 200) 
AND your risk of a hole in the bowel needing emergency surgery is 0.1% (1 in 1000).  The 
chance of cancer in tiny polyps is less than 0.1% (1 in 1000). 
12) What do you think about this policy of expert colonoscopy doctors leaving behind tiny 
polyps that are NOT precancerous?       (Please tick ONE box only) 
☐
 THIS IS A GOOD IDEA: I agree to have my tiny non-precancerous  
polyps left behind. 
☐
 THIS IS A BAD IDEA:   I want to have ALL my tiny polyps removed and 
checked by the pathologist. 
 
Suppose your expert colonoscopist made a mistake and left behind a cancerous polyp. At your 
next colonoscopy 5 years later, the polyp is removed but the cancer has spread to your lymph 
glands and you need surgery. In this example, your chance of staying alive after 5 years is 50%.  
13) Would you seek financial compensation? 
YES ☐  NO ☐   UNSURE ☐ 
If YES, please circle how much money you would want? $100 
$1,000 
$10,000 
$100,000 
$1,000,000 
$10,000,000 
More than $10,000,000 
Other amount: $____________ 
14) If your expert colonoscopy doctor made the above mistake, would you give the doctor 
another chance to leave tiny polyps that are considered NOT precancerous alone? 
YES ☐  NO ☐   UNSURE ☐ 
 
END OF SURVEY 
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Table 1. Suggested areas for further research for implementation of optical diagnosis 
 
1 Financial modeling that combines both “resect and discard” and “diagnose and 
leave” paradigms, adjusted for different rates of patient participation. 
 
2 Determining positive and (correctable) negative predictors of patient acceptance 
to optical diagnosis 
 
3 Assessing the acceptance of endoscopists in performing optical diagnosis in a 
potentially litigious patient population. 
 
 
